Leap Therapeutics, Inc. (LPTX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 209K | 0 | 0 | 234K | 0 | 0 | 0 | 337K | 0 | 0 |
| Revenue Growth % | - | -100% | - | - | - | -30.56% | - | - | - | -80.37% | -100% | -100% |
| Cost of Goods Sold | 0 | 0 | 20.34M | 0 | 0 | 10.67M | 0 | 0 | 0 | 6.11M | 0 | 0 |
| COGS % of Revenue | - | - | 9731.58% | - | - | 4561.54% | - | - | - | 1813.65% | - | - |
| Gross Profit | 0 | 0 | -20.13M | 0 | 0 | -10.44M | 0 | 0 | 0 | -5.78M | 0 | 0 |
| Gross Margin % | - | - | -9631.58% | - | - | -4461.54% | - | - | - | -1713.65% | - | - |
| Gross Profit Growth % | - | 100% | - | - | - | -80.78% | - | - | - | -1494.93% | -100% | -100% |
| Operating Expenses | 4.82M | 576K | 3.17M | 16.88M | 15.92M | 34.54M | 17.86M | 21.25M | 14.82M | 5.9M | 14.83M | 14.66M |
| OpEx % of Revenue | - | - | 1514.83% | - | - | 14762.39% | - | - | - | 1751.04% | - | - |
| Selling, General & Admin | 4.66M | -1.68M | 7.73M | 1.82M | 3.01M | 8.25M | 2.94M | 3.37M | 3.53M | 4.94M | 3.33M | 3.56M |
| SG&A % of Revenue | - | - | 3699.04% | - | - | 3523.93% | - | - | - | 1465.88% | - | - |
| Research & Development | 161K | 975K | 20.34M | 10.54M | 12.91M | 12.88M | 14.91M | 17.89M | 11.3M | 7.08M | 11.5M | 11.1M |
| R&D % of Revenue | - | - | 9731.58% | - | - | 5505.56% | - | - | - | 2100.89% | - | - |
| Other Operating Expenses | 0 | 1000K | -1000K | 1000K | 0 | 1000K | 0 | 0 | 0 | -1000K | 0 | 0 |
| Operating Income | -4.82M | -5.1M | -3.17M | -16.88M | -15.92M | -44.98M | -17.86M | -21.25M | -14.82M | -11.68M | -14.83M | -14.66M |
| Operating Margin % | - | - | -1514.83% | - | - | -19223.93% | - | - | - | -3464.69% | - | - |
| Operating Income Growth % | 69.74% | 88.66% | 82.27% | 20.57% | -7.37% | -285.27% | -20.37% | -44.95% | 65.3% | -177.47% | -252.5% | -596.2% |
| EBITDA | -4.82M | -5.1M | -3.17M | -16.64M | -15.43M | -44.28M | -18.35M | -21.05M | -14.82M | -11.44M | -14.83M | -14.46M |
| EBITDA Margin % | - | - | -1514.83% | - | - | -18923.93% | - | - | - | -3393.18% | - | - |
| EBITDA Growth % | 68.78% | 88.48% | 82.75% | 20.97% | -4.11% | -287.25% | -23.76% | -45.61% | 65.31% | -463.3% | -259.52% | -614.58% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 702K | 0 | 202K | 5K | 241K | 3K | 206K |
| EBIT | -4.82M | -5.1M | -3.17M | -16.64M | -15.43M | -20.89M | -18.35M | -21M | -13.82M | -11.7M | -14.28M | -14.36M |
| Net Interest Income | 88K | 109K | 113K | 239K | 431K | 595K | 894K | 865K | 775K | 938K | 1.08M | 1.16M |
| Interest Income | 95K | 110K | 123K | 246K | 437K | 595K | 894K | 865K | 775K | 938K | 1.08M | 1.16M |
| Interest Expense | 7K | 1K | 10K | 7K | 6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -77.47M | 45.83M | 65K | 238K | 482K | 2.78M | 387K | 1.12M | 1M | 33K | 1.14M | 1.27M |
| Pretax Income | -82.28M | 45.26M | -3.1M | -16.64M | -15.44M | -42.21M | -17.47M | -20.13M | -13.82M | -11.64M | -13.7M | -13.39M |
| Pretax Margin % | - | - | -1483.73% | - | - | -18037.18% | - | - | - | -3454.9% | - | - |
| Income Tax | -5.12M | 5.05M | 202K | 0 | 0 | -2.1M | 708K | 0 | 0 | 7.85M | 0 | 0 |
| Effective Tax Rate % | 6.22% | 11.17% | -6.51% | 0% | 0% | 4.97% | -4.05% | 0% | 0% | -67.41% | 0% | 0% |
| Net Income | -77.17M | 62.87M | -25.97M | -16.64M | -15.44M | -40.17M | -18.18M | -20.13M | -13.82M | -24.68M | -13.7M | -13.39M |
| Net Margin % | - | - | -12425.36% | - | - | -17166.24% | - | - | - | -7321.96% | - | - |
| Net Income Growth % | -399.94% | 256.51% | -42.88% | 17.31% | -11.69% | -62.79% | -32.71% | -50.32% | 66.99% | -506.56% | -236.68% | -544.37% |
| Net Income (Continuing) | -77.17M | 40.2M | -25.97M | -16.64M | -15.44M | -40.11M | -18.18M | -20.13M | -13.82M | -19.49M | -13.7M | -13.39M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | -59K | 0 | 0 | 0 | -1000K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.46 | 0.92 | -0.08 | -0.40 | -0.37 | -0.37 | -0.44 | -0.51 | -0.51 | -0.46 | -0.51 | -0.91 |
| EPS Growth % | -24.32% | 348.65% | 81.82% | 21.57% | 27.45% | 19.57% | 13.73% | 43.96% | 83.91% | 57.01% | 63.57% | 42.04% |
| EPS (Basic) | -0.46 | 0.93 | -0.08 | -0.40 | -0.37 | -0.37 | -0.44 | -0.51 | -0.51 | -0.46 | -0.51 | -0.91 |
| Diluted Shares Outstanding | 168.1M | 70.67M | 41.44M | 41.44M | 41.27M | 41.25M | 41.21M | 39.12M | 27.01M | 26.99M | 26.99M | 14.71M |
| Basic Shares Outstanding | 168.1M | 66.14M | 41.44M | 41.44M | 41.27M | 41.25M | 41.21M | 39.12M | 27.01M | 26.99M | 26.99M | 14.71M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |